Dragon Pharma Tesamorelin
For athletes, bodybuilders, and fitness enthusiasts, body composition is a critical factor in performance and aesthetics. Visceral adipose tissue (VAT)—the deep abdominal fat surrounding internal organs—is particularly challenging to address and has significant metabolic implications. Tesamorelin is a potent growth hormone-releasing hormone (GHRH) analog that has been extensively studied for its ability to reduce visceral fat, improve body composition, and enhance metabolic health. This Dragon Pharma Tesamorelin 5mg offering delivers high-purity lyophilized powder in a sterile 2mL vial, providing researchers with a premium compound for advanced visceral fat, metabolic, and body composition research.
Tesamorelin functions as a GHRH analog, binding to GHRH receptors on the pituitary gland to stimulate the synthesis and release of endogenous growth hormone. By restoring GH levels to more youthful patterns, Tesamorelin promotes lipolysis (fat breakdown), particularly in visceral adipose tissue. Research published in the NIH PubMed database demonstrates that Tesamorelin significantly reduces visceral fat, improves lipid profiles, and enhances insulin sensitivity in research models. Its targeted effect on visceral fat—rather than subcutaneous fat—makes it a unique and valuable tool for metabolic and body composition research.
The relevance of Tesamorelin to the athletic and bodybuilding community is significant. Visceral fat accumulation can be exacerbated by factors such as stress, hormonal fluctuations, and metabolic changes associated with training cycles. Tesamorelin's ability to selectively reduce VAT while improving growth hormone dynamics offers researchers a tool to study targeted fat loss, metabolic health, and body composition optimization. Unlike many metabolic compounds, Tesamorelin's mechanism works through natural GH stimulation, supporting a range of anabolic and metabolic effects including improved protein synthesis, collagen formation, and recovery. The 5mg vial provides a convenient size for research protocols requiring precise dosing.
Quality assurance is paramount in peptide research. Each batch of our Tesamorelin 5 mg inventory undergoes rigorous third-party HPLC-MS testing to verify purity and dosage. Lab test documentation will be available shortly, reflecting Dragon Pharma's commitment to transparency and quality across all products.
For bodybuilders and strength athletes researching advanced body composition strategies, Tesamorelin offers a well-characterized tool for studying visceral fat reduction and metabolic health. Its unique ability to target deep abdominal fat distinguishes it from other growth hormone secretagogues. Whether investigating strategies for metabolic health optimization, body composition improvement, or recovery enhancement, Dragon Pharma's Tesamorelin delivers the purity, potency, and reliability required for serious research into growth hormone physiology and adipose tissue biology.
Note: This product is intended for laboratory research and scientific investigation purposes only. Not for human consumption or veterinary use.
Usage Guidelines
Tesamorelin is supplied as a sterile lyophilized powder and must be reconstituted with bacteriostatic water prior to research use. For optimal stability, gently swirl the vial after adding the diluent—do not shake vigorously. Standard research protocols involve reconstituting the 5mg peptide with 2-4mL of bacteriostatic water, yielding a concentration of 1.25-2.5mg/mL. Typical research dosing ranges from 1-2mg per administration, often administered daily via subcutaneous injection. For optimal GH stimulation, administer in the evening or as directed by protocol. It is recommended to store the reconstituted peptide in a refrigerator (2-8°C) and use within 30 days to maintain peptide integrity.
For researchers investigating comprehensive body composition and metabolic health protocols, combining Tesamorelin with complementary compounds can yield synergistic insights. Consider exploring the following Dragon Pharma products to enhance your research:
- Ipamorelin: A selective GHRP studied alongside GHRH analogs for enhanced GH pulsatility research.
- CJC 1295 No DAC/Ipamorelin: A GHRH/GHRP blend for comparative research on GH stimulation mechanisms.
- Sermorelin: A GHRH analog for comparative research on GH release profiles.